Integer - ITGR Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ITGR shares.
View ITGR analyst ratings or view top-rated stocks.

1 brokerages have issued 12-month target prices for Integer's shares. Their ITGR share price forecasts range from $84.00 to $90.00. On average, they predict the company's share price to reach $87.00 in the next twelve months. This suggests a possible upside of 23.0% from the stock's current price.
View analysts price targets for ITGR or view top-rated stocks among Wall Street analysts.

Integer's stock was trading at $68.46 at the beginning of 2023. Since then, ITGR shares have increased by 3.3% and is now trading at $70.74.
View the best growth stocks for 2023 here.

Integer saw a decline in short interest during the month of December. As of December 30th, there was short interest totaling 690,900 shares, a decline of 11.0% from the December 15th total of 775,900 shares. Based on an average trading volume of 217,600 shares, the short-interest ratio is currently 3.2 days. Approximately 2.1% of the company's shares are sold short.
View Integer's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our ITGR earnings forecast.

Integer Holdings Co. (NYSE:ITGR) announced its quarterly earnings data on Thursday, October, 28th. The medical equipment provider reported $1.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.09. The medical equipment provider had revenue of $305.57 million for the quarter, compared to the consensus estimate of $303.23 million. Integer had a trailing twelve-month return on equity of 9.24% and a net margin of 5.47%. The business's revenue was up 29.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.50 EPS.

Integer issued an update on its fourth quarter earnings guidance on Monday, January, 30th. The company provided earnings per share guidance of $1.08-1.11 for the period, compared to the consensus estimate of $1.02. The company issued revenue guidance of $370-372 million, compared to the consensus revenue estimate of $356.45 million.

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Integer's stock is owned by a variety of institutional and retail investors. Top institutional investors include New York State Common Retirement Fund (1.37%), Allspring Global Investments Holdings LLC (1.05%), Tributary Capital Management LLC (0.83%), Congress Asset Management Co. MA (0.76%), Scout Investments Inc. (0.33%) and Lapides Asset Management LLC (0.21%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends.

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ITGR stock can currently be purchased for approximately $70.74.

Integer (NYSE:ITGR) has a market capitalization of $2.34 billion and generates $1.32 billion in revenue each year. The medical equipment provider earns $96.81 million in net income (profit) each year or $2.15 on an earnings per share basis.

The company employs 9,000 workers across the globe.

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The official website for the company is www.integer.net. The medical equipment provider can be reached via phone at (214) 618-5243, via email at ir@integer.net, or via fax at 716-759-5654.